{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:03:31Z","timestamp":1790042611662,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":2072,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ad.2012.11.020","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T20:00:41Z","timestamp":1363896041000},"page":"558-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Opciones terap\u00e9uticas actuales para los angiofibromas faciales"],"prefix":"10.1016","volume":"105","author":[{"given":"R.","family":"Salido-Vallejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Garnacho-Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Moreno-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2012.11.020_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2012.11.020_bib0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BST0370259","article-title":"Therapeutic targeting of mTOR in tuberous sclerosis","volume":"37","author":"Sampson","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ad.2012.11.020_bib0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2011.04.002","article-title":"Folliculocystic and collagen hamartoma of tuberous sclerosis complex","volume":"66","author":"Torrelo","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0020","first-page":"81","article-title":"Scl\u00e9rose tub\u00e9reuse des circonvolutions c\u00e9r\u00e9brales: Idiotie et \u00e9pilepsie hemipl\u00e9gique","volume":"1","author":"Bourneville","year":"1880","journal-title":"Arch Neurol (Paris)"},{"key":"10.1016\/j.ad.2012.11.020_bib0025","first-page":"1","article-title":"A case of congenital adenoma sebaceum","volume":"2","author":"Pringle","year":"1890","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0030","first-page":"810","article-title":"Tumors and tumor-like proliferations of fibrous and related tissues","author":"Weedon","year":"2010"},{"key":"10.1016\/j.ad.2012.11.020_bib0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0001-7310(08)74972-X","article-title":"Multiple unilateral facial angiofibromas: description of a new case","volume":"99","author":"Bordel-Gomez","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.11.020_bib0040","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1067\/mjd.2003.146","article-title":"Segmental tuberous sclerosis presenting as unilateral facial angiofibromas","volume":"49","author":"Trauner","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ad.2012.11.020_bib0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archderm.134.6.760","article-title":"Clustered angiofibromas on the ear of a patient with neurofibromatosis type 2","volume":"134","author":"Jaffe","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0055","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.jaad.2004.11.021","article-title":"Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dube syndrome","volume":"53","author":"Schaffer","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ajmg.a.33320","article-title":"Absence of signs of systemic involvement in four patients with bilateral multiple facial angiofibromas","volume":"152A","author":"Hunter","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ad.2012.11.020_bib0070","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","article-title":"Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex","volume":"11","author":"Muzykewicz","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ad.2012.11.020_bib0075","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/08830738040190090601","article-title":"Behavioral and cognitive aspects of tuberous sclerosis complex","volume":"19","author":"Prather","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ad.2012.11.020_bib0080","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-3083.2011.04212.x","article-title":"Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis-associated facial angiofibroma","volume":"26","author":"Salido","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.11.020_bib0085","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1590\/S0365-05962011000700048","article-title":"Multiple facial angiofibromas treated with high-frequency equipment","volume":"86","author":"Gomes","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0974-2077.44166","article-title":"Radiofrequency ablation of adenoma sebaceum","volume":"1","author":"Swaroop","year":"2008","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00000637-198002000-00015","article-title":"The use of cryosurgery in treating the fibrous papules of tuberous sclerosis","volume":"4","author":"Dvir","year":"1980","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1684\/ejd.2010.0953","article-title":"Cryosurgery: an easy and cheap therapy for facial angiofibromas in tuberous sclerosis","volume":"20","author":"Schepis","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0105","first-page":"486","article-title":"Timed surgery for treatment of angiofibromas in tuberous sclerosis","volume":"27","author":"Capurro","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00000637-199204000-00015","article-title":"Shave excision and dermabrasion for facial angiofibroma in tuberous sclerosis","volume":"28","author":"Drake","year":"1992","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bjps.2005.04.021","article-title":"Extensive facial adenoma sebaceum: successful treatment with mechanical dermabrasion: case report","volume":"58","author":"El-Musa","year":"2005","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00000637-200103000-00022","article-title":"Treatment of facial angiofibromas of tuberous sclerosis by shave excision and dermabrasion in a dark-skinned patient","volume":"46","author":"Fischer","year":"2001","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00006534-199610000-00003","article-title":"Treatment of the facial angiofibromas of tuberous sclerosis","volume":"98","author":"Verheyden","year":"1996","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.sap.0000221621.34715.21","article-title":"Treatment of facial angiofibroma of tuberous sclerosis using cultured epithelial autografts","volume":"57","author":"Hori","year":"2006","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00000637-199910000-00017","article-title":"Application of artificial dermis prior to full-thickness skin grafting for resurfacing the nose","volume":"43","author":"Suzuki","year":"1999","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0140","first-page":"541","article-title":"Angiofibroma in tuberous sclerosis--argon laser","volume":"32","author":"Kopera","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-4362.1994.tb02876.x","article-title":"Angiofibroma in tuberous sclerosis--argon laser","volume":"33","author":"Arndt","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/019459988609400106","article-title":"Management of facial angiofibromas in tuberous sclerosis: use of the carbon dioxide laser","volume":"94","author":"Bellack","year":"1986","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1524-4725.1990.tb00041.x","article-title":"Angiofibromas in tuberous sclerosis: comparison of treatment by carbon dioxide and argon laser","volume":"16","author":"Janniger","year":"1990","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.ad.2012.11.020_bib0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0190-9622(95)91814-0","article-title":"Treatment of adenoma sebaceum with the copper vapor laser","volume":"33","author":"Kaufman","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2230.1998.00371.x","article-title":"Successful treatment of adenoma sebaceum with the potassium titanyl phosphate laser","volume":"23","author":"Finch","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/lsm.1090","article-title":"\u00abHot\u00bb KTP-laser treatment of facial angiofibromata","volume":"29","author":"Tope","year":"2001","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ad.2012.11.020_bib0175","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1524-4725.1994.tb03709.x","article-title":"CO2, argon, and pulsed dye laser treatment of angiofibromas","volume":"20","author":"Boixeda","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.ad.2012.11.020_bib0180","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0190-9622(08)81707-0","article-title":"Treatment of angiofibroma with the pulsed tunable dye laser","volume":"29","author":"Hoffman","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2133.2002.04968.x","article-title":"Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis","volume":"147","author":"Papadavid","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1468-3083.2004.01013.x","article-title":"An interesting case of unilateral angiofibromas successfully treated with pulsed dye laser","volume":"18","author":"Sharma","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.11.020_bib0195","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1524-4725.2009.01304.x","article-title":"Treatment of angiofibromas of tuberous sclerosis with 5-aminolevulinic acid blue light photodynamic therapy followed by immediate pulsed dye laser","volume":"35","author":"Weinberger","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2012.11.020_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/lsm.20939","article-title":"New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis","volume":"42","author":"Weiss","year":"2010","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ad.2012.11.020_bib0205","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0001-7310(05)73121-5","article-title":"Long-term follow up of angiofibromas treated with CO2 laser in 23 patients with tuberous sclerosis","volume":"96","author":"Belmar","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.11.020_bib0210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1067\/mjd.2001.116223","article-title":"Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow-up","volume":"45","author":"Bittencourt","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0215","first-page":"2471","article-title":"Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders","volume":"32","author":"Rogosnitzky","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ad.2012.11.020_bib0220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1442-200x.1999.01136.x","article-title":"Effects of tranilast on angiofibromas of tuberous sclerosis","volume":"41","author":"Wang","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ad.2012.11.020_bib0225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1468-3083.2008.03004.x","article-title":"Facial angiofibromas of tuberous sclerosis: successful treatment with podophyllin","volume":"23","author":"Turkmen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.11.020_bib0230","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ad.2012.11.020_bib0235","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2012.11.020_bib0240","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2011.35.6329","article-title":"Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas","volume":"30","author":"Chawla","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2012.11.020_bib0245","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2012.11.020_bib0250","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2012.11.020_bib0255","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2012.11.020_bib0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase iii trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2012.11.020_bib0265","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2012.11.020_bib0270","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1002\/cncr.26165","article-title":"Phase 1\/2 study of everolimus in advanced hepatocellular carcinoma","volume":"117","author":"Zhu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ad.2012.11.020_bib0275","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0280","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.transproceed.2009.06.227","article-title":"Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex","volume":"41","author":"Tarasewicz","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ad.2012.11.020_bib0285","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archdermatol.2010.125","article-title":"Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis","volume":"146","author":"Haemel","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-8-1","article-title":"Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model","volume":"8","author":"Rauktys","year":"2008","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0295","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.2005.06438.x","article-title":"Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial","volume":"152","author":"Ormerod","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0300","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archdermatol.2011.254","article-title":"Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol","volume":"147","author":"DeKlotz","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-0960.2011.00837.x","article-title":"Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients","volume":"53","author":"Foster","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0310","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/09546634.2010.489598","article-title":"Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin","volume":"23","author":"Kaufman McNamara","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2012.11.020_bib0315","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/11634580-000000000-00000","article-title":"Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin","volume":"12","author":"Koenig","year":"2012","journal-title":"Drugs R D"},{"key":"10.1016\/j.ad.2012.11.020_bib0320","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2133.2011.10476.x","article-title":"Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mg\/mL[-1]) in two patients with tuberous sclerosis","volume":"165","author":"Mutizwa","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D36TB7N61M","article-title":"Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response","volume":"18","author":"Truchuelo","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2012.11.020_bib0330","first-page":"165","article-title":"Topical rapamycin solution to treat multiple facial angiofibromas in a patient with tuberous sclerosis","volume":"103","author":"Valeron-Almazan","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.11.020_bib0335","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","article-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity","volume":"165","author":"Wataya-Kaneda","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0340","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.farma.2011.09.006","article-title":"Topical sirolimus 0.4% formulation for treatment of facial angiofibromas","volume":"36","author":"Cuevas Asencio","year":"2012","journal-title":"Farm Hosp"},{"key":"10.1016\/j.ad.2012.11.020_bib0345","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.transproceed.2007.04.013","article-title":"Effect of rapamycin on wound healing: an experimental study","volume":"39","author":"Ekici","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ad.2012.11.020_bib0350","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2011.10591.x","article-title":"Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing","volume":"166","author":"Feldmeyer","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase iii, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ad.2012.11.020_bib0360","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","article-title":"Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial","volume":"92","author":"Alberu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ad.2012.11.020_bib0365","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1200\/JCO.2008.17.7279","article-title":"Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning","volume":"26","author":"Armand","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2012.11.020_bib0370","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2012.11.020_bib0375","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archderm.148.1.138","article-title":"A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex","volume":"148","author":"Wataya-Kaneda","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.11.020_bib0380","unstructured":"The University of Texas Health Science Center; Houston. Topical rapamycin to erase angiofibromas in TSC. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2012 [citado 15 Sep 2012]. Disponible en: http:\/\/clinicaltrials.gov\/show\/NCT01526356 NLM Identifier: NCT01526356."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:02:10Z","timestamp":1757552530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731013000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0001731013000392"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2012.11.020","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opciones terap\u00e9uticas actuales para los angiofibromas faciales","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2012.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Espa\u00f1a, S.L. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}